AI assistant
Sending…
Catheter Precision, Inc. — Director's Dealing 2025
Jan 31, 2025
35479_dirs_2025-01-31_a1f2206b-b7dd-4ade-b9cd-8f60116f5ae7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Catheter Precision, Inc. (VTAK)
CIK: 0001716621
Period of Report: 2025-01-29
Reporting Person: Jacques Marie-Claude (Chief Commercial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-29 | Stock Option | $0.42 | A | 125000 | Acquired | 2035-01-29 | Common stock (125000) | Direct |
Footnotes
F1: 20% exercisable on January 29, 2025, 20% exercisable on January 29, 2026, 20% exercisable on January 29, 2027, 20% exercisable on January 29, 2028, and 20% exercisable on January 29, 2029.
More from Catheter Precision, Inc.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 18
Annual Report
2026
Apr 30
Regulatory Filings
2026
Mar 31
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Feb 12